Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Share News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.00
Bid: 39.10
Ask: 39.25
Change: 0.20 (0.52%)
Spread: 0.15 (0.384%)
Open: 39.00
High: 39.60
Low: 38.50
Prev. Close: 38.80
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: SIMEC seeks repayment delay, Pires invests in AI

Thu, 23rd Feb 2023 19:56

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

SIMEC Atlantis Energy Ltd - Edinburgh-based energy company focused on tidal energy - Asks bondholders to agree to delay repayment of GBP5.0 million debt due on March 31. This is because it will receive funds from annual lease income of its 230 megawatt / 460 megawatt hours battery energy storage solutions project, which it estimates in either the second or third quarter of 2023. In recognition of this deferral and increasing interest rates over past 12 months, bond issuer Atlantis Future Energy will offer an enhanced interest rate of 10% on the AFE 2018 debentures, to accrue from April 1 for the duration of the extension period. Says it continues to progress above project at its Uskmouth site in Wales, with the option agreement for the lease of the land at Uskmouth running until May 23. From then, it expects the company that owns the battery project, Uskmouth Energy Storage Limited, to enter a 30-year lease with the group, triggering the payment of a £4m development premium to SAE around 30 days later. Appoints specialist real estate advisers Gerald Eve LLP as agent to monetise the lease, seeking offers in the region of GBP11.8 million.

----------

Pires Investments PLC - London-based investment company focusing on next-generation technology - Agrees to invest in venture capital fund Sure Valley Ventures III Ltd Partnership alongside cornerstone investor Enterprise Ireland. Initially invests EUR54,000, expects to invest up to EUR5 million over the 10-year life of the fund, providing Pires a 16.7% interest. The fund plans to invest in around 15 high-growth artificial intelligence companies in sectors such as enterprise, immersive technologies and cybersecurity across Ireland. Fund has received EUR30 million in commitments at first close, including EUR15 million from Enterprise Ireland. Pires Director Nicholas Lee says: "The technology sector experienced a challenging 2022 and so, consequently, there are a number of interesting investment opportunities becoming available at attractive valuations. The directors therefore believe that this is an ideal time to invest in a new technology focused fund."

----------

Corre Energy BV - Groningen, Netherlands-based renewable energy storage solutions and green hydrogen producer - Raises EUR8.9 million through placing of 2.0 million shares and 529,810 subscribed shares at a placing price of USD3.50 per share. Says placing price represents a discount of approximately 10% to the closing mid-market price of EUR3.90 on Tuesday. Said on Wednesday proceeds to go towards progressing firm's Zuidwending asset in Netherlands and Green Hydrogen Hub in Denmark. Chief Executive Officer Keith McGrane says: "It is a great endorsement of the company and recognises the progress made regarding our near-term projects and positions the company well for further growth."

----------

Logistics Development Group PLC - London-based investment company - Buys additional 5.8 million shares in Alliance Pharma PLC at an average price of GBP0.5911 per share or total GBP3.5 million cash consideration. Now has an interest in 18.7 million Alliance Pharma shares or 3.5% of share capital.

----------

By Greg Rosenvinge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
12 Dec 2019 16:11

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
27 Nov 2019 15:00

Alliance Pharma handing back 'Xonvea' rights to Duchesnay

(Sharecast News) - Alliance Pharma has reached agreement with Duchesnay of Canada to return the UK and EU licensing rights to 'Xonvea', a prescription medicine for the treatment of nausea and vomiting of pregnancy where conservative management has failed, it announced on Wednesday.

Read more
27 Nov 2019 12:33

Alliance Pharma Exits Xonvea Licensing Deal Amid Slow Sales Uptake

Alliance Pharma Exits Xonvea Licensing Deal Amid Slow Sales Uptake

Read more
17 Sep 2019 16:12

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 18 September KingfisherHalf Year ResultsAccesso TechnologyHalf Year Year Year

Read more
10 Jul 2019 16:12

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 11 July Kenmare ResourcesHalf Year ProductionMcBrideTrading GroupFull

Read more
1 Jul 2019 15:35

Alliance Pharma Founder & Former Chief Executive John Dawson Departs

(Alliance News) - Alliance Pharma PLC said on Monday founder & former chief executive John Dawson decided to step down from the board.Dawson, who was a non-executive director at the on

Read more
16 May 2019 17:55

UK Shareholder Meetings Calendar - Next 7 Days

Friday 17 MayRestaurant GroupBank of Georgia GroupCentaur MediaCairn Continental 20

Read more
10 Apr 2019 16:05

Alliance Pharma's 'Xonvea' gets approval in Ireland

(Sharecast News) - Alliance Pharma announced on Wednesday that 'Xonvea' has gained marketing approval in the Republic of Ireland from the country's medicines regulator, the Health Products Regulatory Authority, for the treatment of nausea and vomiting of pregnancy where conservative management has failed.

Read more
10 Apr 2019 12:27

Alliance Pharma Gets Approval For Anti-Nausea Drug Xonvea In Ireland

LONDON (Alliance News) - Alliance Pharma PLC on Wednesday said its Xonvea drug has been approved in Ireland to treat nausea and vomiting of pregnancy.The Irish marketing approval is first

Read more
26 Mar 2019 11:33

Alliance Pharma Raises Annual Dividend Amid Strong Revenue Growth

LONDON (Alliance News) - Alliance Pharma on Tuesday raised its dividend for 2018 amid a strong revenue performance, though profit fell due to impairments.The pharmaceutical retailer said to

Read more
19 Mar 2019 16:07

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 20 March KingfisherFull Year ResultsCentaur MediaFull Year GroupHalf

Read more
21 Jan 2019 12:42

Alliance Pharma's revenues climb as 'star' products shine

(Sharecast News) - Alliance Pharma on Monday reported a jump in revenue after a strong performance from its 'star' products and newly acquired Nizoral brand.

Read more
14 Jan 2019 15:59

UK Earnings, Trading Statements Calendar - Next 7 Days

Tuesday 15 January Boohoo GroupTrading Statement Gym GroupTrading Workshop Year Year

Read more
2 Oct 2018 09:56

Alliance Pharma launches Xonvea in the UK

(Sharecast News) - Alliance Pharma launched its prescription product for the treatment of nausea and vomiting of pregnancy across the UK on Tuesday.

Read more
1 Oct 2018 13:02

Strategic Equity Capital Underperforms Against Benchmark In Year

LONDON (Alliance News) - Strategic Equity Capital PLC said on Monday it underperformed against its benchmark for its recently ended financial year, due to an undervalued portfolio.The said

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.